1. Merck says molnupiravir has favourable benefit-risk assessment

   News item 04 December 2021 Pages: 1 - 1

2. New pre-vaccination checklist for yellow fever vaccine

   News item 04 December 2021 Pages: 2 - 2

3. Package insert altered for sclerosing cholangitis with atezolizumab

   News item 04 December 2021 Pages: 3 - 3

4. Reducing risk of brolucizumab-related intraocular inflammation

   News item 04 December 2021 Pages: 4 - 4

5. Voluntary recall of Sagent Pharmaceuticals' levetiracetam injection

   News item 04 December 2021 Pages: 5 - 5

6. Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador

   Clinical study 04 December 2021 Pages: 6 - 6

7. Aspirin use increases risk of heart failure

   Clinical study 04 December 2021 Pages: 7 - 7

8. Exposure to valproate in women of childbearing age high in India

   Clinical study 04 December 2021 Pages: 8 - 8

9. No increase in stroke, MI or PE after Pfizer-BioNTech COVID-19 vaccine

   Clinical study 04 December 2021 Pages: 9 - 9

10. Pfizer-BioNTech COVID-19 vaccine safe in older Koreans

    Clinical study 04 December 2021 Pages: 10 - 10

11. Risk-benefit of AstraZeneca COVID-19 vaccination in Australia

    Clinical study 04 December 2021 Pages: 11 - 11

12. Tigecycline-associated liver injury in Chinese patients

    Clinical study 04 December 2021 Pages: 12 - 12

13. Other adverse reaction research

    News item 04 December 2021 Pages: 13 - 13

14. Abatacept/etanercept

    Case report 04 December 2021 Pages: 14 - 14

15. Abemaciclib

    Case report 04 December 2021 Pages: 15 - 15

16. Abiraterone/enzalutamide

    Case report 04 December 2021 Pages: 16 - 16

17. Acetylcysteine/ascorbic-acid/benzylpenicillin

    Case report 04 December 2021 Pages: 17 - 17

18. Aciclovir

    Case report 04 December 2021 Pages: 18 - 18

19. Ad26.cov2-s

    Case report 04 December 2021 Pages: 19 - 19

20. Adalimumab

    Case report 04 December 2021 Pages: 20 - 20

21. Adalimumab

    Case report 04 December 2021 Pages: 21 - 21

22. Adalimumab

    Case report 04 December 2021 Pages: 22 - 22

23. Adalimumab/infliximab/methotrexate

    Case report 04 December 2021 Pages: 23 - 23

24. Adalimumab/methotrexate

    Case report 04 December 2021 Pages: 24 - 24

25. Adenosine

    Case report 04 December 2021 Pages: 25 - 25

26. Afatinib/bevacizumab

    Case report 04 December 2021 Pages: 26 - 26

27. Alemtuzumab/cladribine/natalizumab

    Case report 04 December 2021 Pages: 27 - 27

28. Alemtuzumab/varicella-zoster-virus-vaccine-live

    Case report 04 December 2021 Pages: 28 - 28

29. Alprazolam/carminatives/nonsteroidal anti inflammatories

    Case report 04 December 2021 Pages: 29 - 29

30. Alteplase/heparin

    Case report 04 December 2021 Pages: 30 - 30

31. Amiloride/spironolactone

    Case report 04 December 2021 Pages: 31 - 31

32. Amiodarone

    Case report 04 December 2021 Pages: 32 - 32

33. Amiodarone/antiarrhythmics/milrinone

    Case report 04 December 2021 Pages: 33 - 33

34. Amiodarone/metoprolol/propafenone

    Case report 04 December 2021 Pages: 34 - 34

35. Amphotericin-B-liposomal

    Case report 04 December 2021 Pages: 35 - 35

36. Amphotericin-B-liposomal/cytarabine/daunorubicin

    Case report 04 December 2021 Pages: 36 - 36

37. Ampicillin/sulbactam

    Case report 04 December 2021 Pages: 37 - 37

38. Anakinra

    Case report 04 December 2021 Pages: 38 - 38

39. Antiarrhythmics

    Case report 04 December 2021 Pages: 39 - 39

40. Antibacterials/interferon/remdesivir

    Case report 04 December 2021 Pages: 40 - 40

41. Antiepileptic drugs/hypnosedatives

    Case report 04 December 2021 Pages: 41 - 41

42. Antiepileptic-drugs

    Case report 04 December 2021 Pages: 42 - 42

43. Antihyperglycaemics/bucolome/warfarin

    Case report 04 December 2021 Pages: 43 - 43

44. Antineoplastics

    Case report 04 December 2021 Pages: 44 - 44

45. Antineoplastics

    Case report 04 December 2021 Pages: 45 - 45

46. Antineoplastics

    Case report 04 December 2021 Pages: 46 - 46

47. Antineoplastics

    Case report 04 December 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 04 December 2021 Pages: 48 - 48

49. Antineoplastics

    Case report 04 December 2021 Pages: 49 - 49

50. Antineoplastics

    Case report 04 December 2021 Pages: 50 - 50